HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural and functional analysis of ataxin-2 and ataxin-3.

Abstract
Spinocerebellar ataxia types 2 (SCA2) and 3 (SCA3) are autosomal-dominantly inherited, neurodegenerative diseases caused by CAG repeat expansions in the coding regions of the genes encoding ataxin-2 and ataxin-3, respectively. To provide a rationale for further functional experiments, we explored the protein architectures of ataxin-2 and ataxin-3. Using structure-based multiple sequence alignments of homologous proteins, we investigated domains, sequence motifs, and interaction partners. Our analyses focused on presumably functional amino acids and the construction of tertiary structure models of the RNA-binding Lsm domain of ataxin-2 and the deubiquitinating Josephin domain of ataxin-3. We also speculate about distant evolutionary relationships of ubiquitin-binding UIM, GAT, UBA and CUE domains and helical ANTH and UBX domain extensions.
AuthorsMario Albrecht, Michael Golatta, Ullrich Wüllner, Thomas Lengauer
JournalEuropean journal of biochemistry (Eur J Biochem) Vol. 271 Issue 15 Pg. 3155-70 (Aug 2004) ISSN: 0014-2956 [Print] England
PMID15265035 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ataxins
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Peptides
  • Proteins
  • Repressor Proteins
  • Ubiquitin
  • polyglutamine
  • RNA
  • ATXN3 protein, human
  • Ataxin-3
Topics
  • Amino Acid Sequence
  • Animals
  • Ataxin-3
  • Ataxins
  • Humans
  • Models, Molecular
  • Molecular Sequence Data
  • Nerve Tissue Proteins (chemistry, metabolism)
  • Nuclear Proteins
  • Peptides (chemistry, metabolism)
  • Protein Binding
  • Protein Structure, Tertiary
  • Proteins (chemistry, metabolism)
  • RNA (metabolism)
  • Repressor Proteins
  • Sequence Alignment
  • Structure-Activity Relationship
  • Ubiquitin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: